LPTX
NASDAQ
Leap Therapeutics, Inc. - Common Stock
Healthcare
· Biotechnology
$1.11
+0.03 (+2.8%)
1
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$25.3M
ROE
-237.7%
Margin
-2705.8%
D/E
0.00
Beta
0.10
52W
$0–$5
Price Chart
Fundamentals Trend
| Metric | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -137.1% | -162.2% | -237.7% | -237.7% | -237.7% | -237.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | -2705.8% | -2705.8% | -2705.8% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.41 | 2.41 | 1.34 | 1.34 | 1.34 | 1.34 |
Key Ratios
ROA (TTM)
-155.4%
P/S (TTM)
16.89
P/B
3.1
EPS (TTM)
$-1.59
CF/Share
$-4.91
52W High
$4.79
52W Low
$0.22
$0.22
52-Week Range
$4.79
How does LPTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
LPTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
16.9
▲
31%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
3.1
▲
28%
above
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
LPTX profitability vs Biotechnology peers
ROE
-237.7%
▼
253%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-2705.8%
▼
844%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-155.4%
▼
233%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
LPTX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
1.3
▼
70%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.1
▼
90%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
LPTX fundamentals radar
LPTX
Peer median
Industry
LPTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
LPTX vs peers: key metrics
Latest News
No related news yet